Notably, combination treatment with lower dose of metformin (0.1 mmol/L) and liraglutide (3 nmol/L) had a significant protective effect on the PA-induced upregulation of ROS production and reduction of NO level and p-eNOS protein level (Fig
Modelling of treatment response We aimed to build models of treatment response that combined both genetic and non-genetic predictors
Our goal is to help patients understand their options clearly and choose a plan that matches their body, health history, and long-term goals
For those who meet the eligibility criteria, GLP-1 injections remain the most reliable option for weight loss
Gastrointestinal side effect timing Beyond nausea, GLP-1 agonists can cause constipation, diarrhea, bloating, and acid reflux
The most important thing is to stay consistent once youve made the change, and to make sure youre not taking doses too close together during the transition